Immunic, Inc. is trading 8.1% up at $13.25 in after-hours trading, rebounding from a recent multi-day slide.
- The move appears driven by bargain hunting and a technical recovery following sharp declines earlier in June.
- No new fundamental developments or company-specific catalysts have been reported to account for the price action.
- The stock is staging a recovery despite the absence of fresh sector-wide news or specific triggers.